Contact Us    855-RIA-PLAN (855-742-7526)

MRNS: Marinus Pharmaceuticals Inc Stock

By | July 6, 2018

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 386.05
Enterprise Value ($M) 285.83
Book Value ($M) 78.49
Book Value / Share 2.13
Price / Book 4.92
NCAV ($M) 73.11
NCAV / Share 1.99
Price / NCAV 5.28

Profitability (mra)
Return on Invested Capital (ROIC) -0.72
Return on Assets (ROA) -0.58
Return on Equity (ROE) -0.64

Liquidity (mrq)
Quick Ratio 4.07
Current Ratio 4.07

Balance Sheet (mrq) ($M)
Current Assets 153.49
Assets 158.87
Liabilities 80.38
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
08-20 13G Suvretta Capital Management, Llc 5.60
02-16 13G/A Bain Capital Life Sciences Fund, L.P. 3.60 -75.92
02-16 13G/A Venrock Healthcare Capital Partners II, L.P. 7.30 -60.19
02-12 13G/A Avoro Capital Advisors LLC 9.09 -68.94
02-12 13G/A Lion Point Capital, LP 12.20 -28.33
02-11 13G/A Adage Capital Partners Gp, L.l.c. 4.11 -69.53
02-02 13G BlackRock Inc. 5.80
2021-01-11 13G 683 Capital Management, LLC 5.10

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2021-08-10 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2021-05-17 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2021-03-09 10-K Annual Report – 10-K

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2022-01-18 15,370 96,371 15.95
2022-01-13 37,407 106,533 35.11

(click for more detail)

(click for list of largest short owners)

Similar Companies
MREO – Mereo BioPharma Group plc MRKR – Marker Therapeutics Inc
MRNA – Moderna Inc MRSN – Mersana Therapeutics Inc
MRTX – Mirati Therapeutics Inc


Financial data and stock pages provided by
Fintel.io


Finpedia: Marinus Pharmaceuticals





2018/07/06
> Back to All Posts